Author

G. M. Torres

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:mouse· 1 Assay:protein structure· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

B. S. Graham· 1 shared B. Schepens· 1 shared C. Park· 1 shared C.-Y. Wang· 1 shared D. De Vlieger· 1 shared D. Wrapp· 1 shared F. W. Kolling· 1 shared H. C. Jarnagin· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

B. S. Graham

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CDDO-Methyl Ester Inhibits BRAF Inhibitor Resistance and Remodels the Myeloid Compartment in BRAF-mutant Melanoma

G. M. Torres, H. C. Jarnagin, C. Park, H. Yang, N. N. Kosarek, R. Bhandari, C.-Y. Wang, F. W. Kolling, M. L. Whitfield, M. J. Turk, K. T. Liby, P. A. Pioli

This study shows that CDDO-Methyl Ester reduces BRAF inhibitor resistance in melanoma by altering the tumor microenvironment and myeloid cell composition.

bioRxiv · Aug 1, 2023 · PreprintImmunology

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies

D. Wrapp, D. De Vlieger, K. S. Corbett, G. M. Torres, W. Van Breedam, K. Roose, L. van Schie, VIB-CMB COVID-19 Response Team, M. Hoffmann, S. Pöhlmann, B. S. Graham, N. Callewaert, B. Schepens, X. Saelens, J. S. McLellan

This study isolates and characterizes VHH antibodies that neutralize MERS-CoV, SARS-CoV-1, and SARS-CoV-2 by blocking receptor binding, with structural insights into their epitopes and cross-reactivity.

bioRxiv · Mar 26, 2020Microbiology